Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,338,036
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
13,093,349
-
Shares change
-
+2,309,787
-
Total reported value, excl. options
-
$114,176,966
-
Value change
-
+$20,438,436
-
Number of buys
-
31
-
Number of sells
-
10
-
Price
-
$8.72
Institutional Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) as of Q3 2023
As of 30 Sep 2023 Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,093,349 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, Boxer Capital, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This table shows 48 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.